The efficacy and safety of bevacizumab beyond first progression in patients treated with first-line mFOLFOX6 followed by second-line FOLFIRI in advanced colorectal cancer: a multicenter, single-arm, phase II trial (CCOG-0801) - Concepedia

Concepedia

Publication | Open Access

The efficacy and safety of bevacizumab beyond first progression in patients treated with first-line mFOLFOX6 followed by second-line FOLFIRI in advanced colorectal cancer: a multicenter, single-arm, phase II trial (CCOG-0801)

DOI Full Paper Access

12

Citations

13

References

2012

Year

Goro Nakayama, Keisuke Uehara, Kiyoshi Ishigure, Hiroyuki Yokoyama, Akiharu Ishiyama, Takehiko Eguchi, Kenji Tsuboi, Norifumi Ohashi, Tsutomu Fujii, Hiroyuki Sugimoto,

Cancer Chemotherapy and Pharmacology

References

	Year	Citations

Page 1